Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$8.6 - $14.94 $258,000 - $448,200
30,000 New
30,000 $447,000
Q3 2020

Nov 12, 2020

SELL
$21.1 - $29.13 $578,140 - $798,162
-27,400 Reduced 81.79%
6,100 $170,000
Q2 2020

Aug 12, 2020

SELL
$18.94 - $24.93 $564,412 - $742,914
-29,800 Reduced 47.08%
33,500 $719,000
Q1 2020

May 13, 2020

BUY
$16.68 - $32.25 $343,608 - $664,350
20,600 Added 48.24%
63,300 $1.42 Million
Q4 2019

Feb 10, 2020

SELL
$25.29 - $29.45 $634,779 - $739,195
-25,100 Reduced 37.02%
42,700 $1.26 Million
Q3 2019

Nov 14, 2019

BUY
$25.62 - $34.96 $1.73 Million - $2.36 Million
67,600 Added 33800.0%
67,800 $1.8 Million
Q2 2019

Aug 14, 2019

BUY
$31.11 - $34.79 $6,222 - $6,958
200 New
200 $7,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.